No disclosed counterparties: AME, DHR.
| Stage | AME | % of rev | DHR | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $2.2B | 100.00% | $6.6B | 100.00% | DHR ×2.95 |
| Gross profit | $810M | 36.50% | $3.8B | 58.54% | DHR +22.0pp |
| Operating income | $585M | 26.35% | $1.2B | 19.00% | AME +7.3pp |
| Pre-tax income | $522M | 23.51% | $1.1B | 17.27% | AME +6.2pp |
| Net income | $426M | 19.20% | $1.2B | 18.84% | AME +0.4pp |
| Stage | AME | DHR | Gap · A − B |
|---|---|---|---|
| Revenue | $2.2B100.00% | $6.6B100.00% | DHR ×2.95 |
| Gross profit | 36.50%$810M | 58.54%$3.8B | DHR +22.0pp |
| Operating income | 26.35%$585M | 19.00%$1.2B | AME +7.3pp |
| Pre-tax income | 23.51%$522M | 17.27%$1.1B | AME +6.2pp |
| Net income |
| 19.20%$426M |
| 18.84%$1.2B |
| AME +0.4pp |